Target intelligence / Profile preview

Ribosomal protein L31 pseudogene 20 (RPL31P20)

Target
RPL31P20
Molecular classification
Other (Pseudogene)
01

Overview

RPL31P20 is a processed pseudogene resulting from retrotransposition of the functional RPL31 gene, which encodes a component of the 60S ribosomal subunit[7][2]. Like other ribosomal protein pseudogenes, RPL31P20 does not produce a functional protein, lacks intrinsic biological activity, and is not implicated directly in disease or drug targeting. Its presence in the genome primarily reflects the evolutionary history of ribosomal protein gene duplication and retrotransposition[2][6]. RPL31P20 is a pseudogene—by definition, it is not functionally expressed and does not encode a protein or active biomolecule[2][7]. It should not be considered a drug target, therapeutic target, or biomarker. No therapies, mechanisms of action, or biological functions are attributed to this entry. If you are seeking information on the therapeutic target, consider the parent gene “Ribosomal protein L31” (RPL31), but not the pseudogene RPL31P20.

Other names
RPL31_6_349RPL31P20

Beyond the preview

Go deeper on Ribosomal protein L31 pseudogene 20 (RPL31P20).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L31 pseudogene 20 (RPL31P20).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call